Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons Z. Diamant

Publicaties

An Update on Patient-Reported Outcomes in Asthma

Effect of Aderamastat (FP-025), A Selective MMP-12 Inhibitor, on Allergen-induced Airway Responses in Subjects With House-dust Mite Allergic Mild Asthma and Blood Eosinophilia

EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care

Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma

Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up

Validation of a method for the determination of Aderamastat (FP-025) in K 2EDTA human plasma by LC-MS/MS

A EUFOREA comment on a lost comorbidity of asthma

Allergen immunotherapy for allergic asthma: The future seems bright

Lees meer